Luminescent silicon nanocrystals as bioimaging systems

Informacje na temat projektu

SiNBioSys

Identyfikator umowy o grant: 780061

DOI

10.3030/780061

Projekt został zamknięty

Data podpisania przez KE 26 Października 2017

Data rozpoczęcia 1 Listopada 2017

Data zakończenia 30 Kwietnia 2019

Finansowanie w ramach

• EXCELLENT SCIENCE - European Research Council (ERC)

Koszt całkowity

€ 149 937,50

Wkład UE

€ 149 937,50

Koordynowany przez

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Italy

Periodic Reporting for period 1 - SiNBioSys (Luminescent silicon nanocrystals as bioimaging systems)

Okres sprawozdawczy: 2017-11-01 do 2019-04-30

Podsumowanie kontekstu i ogólnych celów projektu

SiNBioSys developed luminescent silicon nanocrystals as optical imaging probes. Optical imaging is a powerful tool for light-guided surgery and for the study of biological functions via dynamic visualization of processes in tissues and cells. We demonstrated that silicon nanocrystals offer the following advantages compared to fluorescent markers and conventional quantum dots: silicon is essentially non-toxic, easily available, it can be covalently linked with dyes, the extraordinary brightness of the material coupled to a long-lived luminescence (lifetime of the hundreds of microseconds) enables time-gated detection for an improved contrast of the obtained images.
SiNBioSys developed a commercialization package of the presented technology, consisting of technical tests, market analysis, business plan and IP strategy. This technology was presented to end-users, like physicians, to understand their need and their expectations, and to potential investors and industrial partners: very positive feedbacks were obtained in both cases. The future development will be the creation of a spin-off company.